Private Equity 8 Hours

Last updated: May 27, 2026, 11:30 AM ET

Leadership moves & impact focus EIV Capital promoted Jason Tracton to partner after he steered the firm’s resources business since September 2022, underscoring the firm’s push to deepen sector expertise. At the same time, panelists at the PEI Group Impact Investor Global Summit warned that impact‑focused LPs are adding a new diligence layer to portfolio company CVs to lock in ESG objectives, a practice that could reshape deal structuring. Dutch pension giant APG expanded its impact mandate toward a €10bn target, signaling that large institutional investors are now quantifying impact as a core allocation metric.

Roll‑up activity and strategic acquisitions Modella Capital broadened its high‑street platform with the Flying Tiger Copenhagen acquisition, marking the firm’s most ambitious cross‑border roll‑up to date. In the digital infrastructure space, DigitalBridge agreed to buy ArcLight for $1.05bn, including $650 m upfront and up to $400 m contingent consideration, a move that deepens its data‑center footprint in Europe. Meanwhile, CVC Credit refreshed its stake in Curium with a combined debt‑equity refinancing package, reinforcing the Paris‑based nuclear‑medicine specialist’s growth runway. In the rights‑and‑royalties niche, Hg injected $500 m into Rightsline, bolstering the software provider’s capacity to serve IP‑intensive industries.

Fundraising and credit expansion Placement agents collectively raised $82bn for GP clients in 2024, highlighting the continued appetite for private‑equity capital despite tightening credit markets. KKR and Capital Group prepared an Asia‑focused public‑private credit fund, their first joint venture outside the United States, aimed at capturing the region’s burgeoning corporate‑debt pipeline. Parallel to that, I Squared Capital pledged up to $1bn to launch a U.S. AI‑inference data‑centre platform, reflecting private‑equity’s bet on AI‑driven infrastructure as a long‑term growth engine.

Exits, financing and sector bets CVC Capital Partners exited its eight‑year holding in Naturgy with a €4bn sale of its 13.8% stake, a deal that returns capital to investors while underscoring the firm’s willingness to monetize mature energy assets. In life‑sciences finance, Blackstone Life Sciences structured a $1.3bn royalty‑and‑debt package for Apogee Therapeutics, providing the biotech with non‑dilutive capital to advance its pipeline. Finally, Capchase secured a $200 m financing package—$26 m equity plus a $174 m credit facility, illustrating how growth‑stage fintechs are turning to hybrid capital solutions to fuel expansion without relinquishing control.